RNAi疗法

搜索文档
Arrowhead Pharmaceuticals(ARWR) - 2025 Q1 - Earnings Call Transcript
2025-02-11 06:30
Arrowhead Pharmaceuticals (ARWR) Q1 2025 Earnings Call February 10, 2025 04:30 PM ET Company Participants Vince Anzalone - Vice President, Investor RelationsChristopher Anzalone - President and CEOBruce Gibbon - Interim Chief Medical ScientistAndy Davis - SVP of Cardiovascular & Head of Metabolic FranchiseDr. James Hamilton - Chief Medical OfficerKen Myszkowski - CFOPatrick Trucchio - Managing DirectorMayank Mamtani - Senior Managing DirectorAndrea Newkirk - Biotechnolgy Equity ResearchMani Foroohar - Senio ...